A novel CRX variant (p.R98X) is identified in a Chinese family of Retinitis pigmentosa with atypical and mild manifestations.
CRX
Nonsense mutation
Retinitis pigmentosa (RP)
Whole exome sequence
Journal
Genes & genomics
ISSN: 2092-9293
Titre abrégé: Genes Genomics
Pays: Korea (South)
ID NLM: 101481027
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
03
09
2018
accepted:
04
11
2018
pubmed:
22
11
2018
medline:
14
5
2019
entrez:
22
11
2018
Statut:
ppublish
Résumé
Retinitis pigmentosa (RP) is the most common form of hereditary retinal degeneration that can cause inherited blindness. RP has extreme genetic and clinical heterogeneity, which brings a major obstacle to obtaining an accurate molecular diagnosis. To analyze the genetic defect in a Chinese family of RP with a few atypical manifestations. Whole-exome sequencing (WES) was applied to identify the disease-associated genes. Sanger sequencing was performed to validate the variants of candidate genes in the patient and his parents. In vitro expression analysis was further conducted to examine the potential biological function of the gene variant. A heterozygous nonsense variant c.292C > T (p.R98X) of CRX gene was identified to be present in the affected male. The c.292C > T variant of CRX was absent in all of the searched databases, including the 10,000 Chinese exome database. The nonsense variant was supposed to result in a truncated CRX protein with a destroyed homedomain (HD), which is essential for CRX translation. Interestingly, the following assay showed that the potential truncated protein was not detected, indicating that the variant may cause a loss-of-function mutation of CRX gene. We identified a novel heterozygous null mutation in the CRX gene which was the first evidence of a nonsense mutation in the HD domain of CRX. Our finding suggested that the haploinsufficiency mutation of CRX gene contributed to the atypical and mild manifestations of the autosomal dominant RP in the Chinese family.
Sections du résumé
BACKGROUND
Retinitis pigmentosa (RP) is the most common form of hereditary retinal degeneration that can cause inherited blindness. RP has extreme genetic and clinical heterogeneity, which brings a major obstacle to obtaining an accurate molecular diagnosis.
OBJECTIVE
To analyze the genetic defect in a Chinese family of RP with a few atypical manifestations.
METHODS
Whole-exome sequencing (WES) was applied to identify the disease-associated genes. Sanger sequencing was performed to validate the variants of candidate genes in the patient and his parents. In vitro expression analysis was further conducted to examine the potential biological function of the gene variant.
RESULTS
A heterozygous nonsense variant c.292C > T (p.R98X) of CRX gene was identified to be present in the affected male. The c.292C > T variant of CRX was absent in all of the searched databases, including the 10,000 Chinese exome database. The nonsense variant was supposed to result in a truncated CRX protein with a destroyed homedomain (HD), which is essential for CRX translation. Interestingly, the following assay showed that the potential truncated protein was not detected, indicating that the variant may cause a loss-of-function mutation of CRX gene.
CONCLUSION
We identified a novel heterozygous null mutation in the CRX gene which was the first evidence of a nonsense mutation in the HD domain of CRX. Our finding suggested that the haploinsufficiency mutation of CRX gene contributed to the atypical and mild manifestations of the autosomal dominant RP in the Chinese family.
Identifiants
pubmed: 30460480
doi: 10.1007/s13258-018-0763-4
pii: 10.1007/s13258-018-0763-4
doi:
Substances chimiques
Codon, Nonsense
0
Homeodomain Proteins
0
Trans-Activators
0
cone rod homeobox protein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
359-366Références
Gene. 2013 Apr 25;519(1):173-6
pubmed: 23402891
Oncotarget. 2017 May 23;8(21):35176-35183
pubmed: 28456785
Invest Ophthalmol Vis Sci. 2014 Sep 30;55(10):6934-44
pubmed: 25270190
Eur J Hum Genet. 2013 Mar;21(3):274-80
pubmed: 22968130
Hum Genet. 2014 Oct;133(10):1255-71
pubmed: 24938718
Am J Hum Genet. 2007 Jul;81(1):147-57
pubmed: 17564971
Hum Mutat. 2001 Dec;18(6):488-98
pubmed: 11748842
Invest Ophthalmol Vis Sci. 2011 Jan 25;52(1):494-503
pubmed: 20861475
Dev Dyn. 2014 Oct;243(10):1153-66
pubmed: 24888636
JAMA Ophthalmol. 2017 Feb 1;135(2):137-144
pubmed: 28056120
Nat Genet. 1999 Dec;23(4):466-70
pubmed: 10581037
Mol Vis. 2017 Jul 20;23:470-481
pubmed: 28761320
Sci Rep. 2018 Mar 22;8(1):5034
pubmed: 29568065
Retina. 2017 Jan;37(1):161-172
pubmed: 27380427
Sci Rep. 2017 Feb 03;7:41937
pubmed: 28157192
J Biol Chem. 2000 Nov 24;275(47):37264-70
pubmed: 10984472
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1045-1053
pubmed: 28192796
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4771-80
pubmed: 20393116
Br J Ophthalmol. 1992 Aug;76(8):465-9
pubmed: 1390527
Mol Vis. 2012;18:2411-9
pubmed: 23077400
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1736-1742
pubmed: 28324114
Hum Mutat. 2012 Jun;33(6):963-72
pubmed: 22334370
J Med Genet. 2011 Mar;48(3):145-51
pubmed: 21147909